Zeneca Casodex Clinical Trial Excerpts Cited In FDA Warning Letter

Zeneca's distribution of three leaflets excerpting clinical trial results for the prostate cancer therapy Casodex (bicalutamide) for off-label uses is among promotional activities by the company challenged in a Nov. 24 warning letter.